XML 114 R103.htm IDEA: XBRL DOCUMENT v3.8.0.1
Guarantor Financial Information (Consolidating Statements of Income) (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenues:    
Product sales $ 3,637.1 $ 3,412.3
Royalties and other revenues 128.6 160.0
Total revenues 3,765.7 3,572.3
Costs and expenses:    
Cost of sales 1,132.4 1,327.0
Research and development 405.2 379.3
Selling, general and administrative 804.8 888.9
Amortization of acquired intangible assets 484.0 364.0
Integration and acquisition costs 239.7 116.0
Reorganization costs 5.3 5.5
Gain/(loss) on sale of product rights 0.0 (5.5)
Total operating expenses 3,071.4 3,075.2
Operating income from continuing operations 694.3 497.1
Interest income/(expense), net (124.4) (139.2)
Other income/(expense), net 23.2 4.5
Total other expense, net (101.2) (134.7)
Income from continuing operations before income taxes and equity in earnings/(losses) of equity method investees 593.1 362.4
Income taxes (43.3) (6.8)
Equity in income/(losses) of equity method investees, net of taxes 0.8 (0.8)
Income from continuing operations, net of taxes 550.6 354.8
Gain from discontinued operations, net of taxes 0.0 20.2
Net income 550.6 375.0
Comprehensive income/(loss) 1,021.7 645.5
Eliminations    
Revenues:    
Product sales 0.0 0.0
Royalties and other revenues 0.0 0.0
Total revenues 0.0 0.0
Costs and expenses:    
Cost of sales 0.0 0.0
Research and development 0.0 0.0
Selling, general and administrative 0.0 0.0
Amortization of acquired intangible assets 0.0 0.0
Integration and acquisition costs 0.0 0.0
Reorganization costs 0.0 0.0
Gain/(loss) on sale of product rights   0.0
Total operating expenses 0.0 0.0
Operating income from continuing operations 0.0 0.0
Interest income/(expense), net 0.0 0.0
Other income/(expense), net 0.0 0.0
Total other expense, net 0.0 0.0
Income from continuing operations before income taxes and equity in earnings/(losses) of equity method investees 0.0 0.0
Income taxes 0.0 0.0
Equity in income/(losses) of equity method investees, net of taxes (691.5) (291.0)
Income from continuing operations, net of taxes (691.5) (291.0)
Gain from discontinued operations, net of taxes   0.0
Net income (691.5) (291.0)
Comprehensive income/(loss) (1,662.7) (806.8)
Shire plc (Parent Guarantor)    
Revenues:    
Product sales 0.0 0.0
Royalties and other revenues 0.0 0.0
Total revenues 0.0 0.0
Costs and expenses:    
Cost of sales 0.0 0.0
Research and development 0.0 0.0
Selling, general and administrative 11.9 14.0
Amortization of acquired intangible assets 0.0 0.0
Integration and acquisition costs 4.4 0.0
Reorganization costs 0.0 0.0
Gain/(loss) on sale of product rights   0.0
Total operating expenses 16.3 14.0
Operating income from continuing operations (16.3) (14.0)
Interest income/(expense), net (32.3) (30.3)
Other income/(expense), net (0.6) 0.0
Total other expense, net (32.9) (30.3)
Income from continuing operations before income taxes and equity in earnings/(losses) of equity method investees (49.2) (44.3)
Income taxes 0.9 1.5
Equity in income/(losses) of equity method investees, net of taxes 598.9 417.8
Income from continuing operations, net of taxes 550.6 375.0
Gain from discontinued operations, net of taxes   0.0
Net income 550.6 375.0
Comprehensive income/(loss) 1,021.7 645.5
SAIIDAC (SAIIDAC Notes Subsidiary Issuer)    
Revenues:    
Product sales 0.0 0.0
Royalties and other revenues 0.0 0.0
Total revenues 0.0 0.0
Costs and expenses:    
Cost of sales 0.0 0.0
Research and development 0.0 0.0
Selling, general and administrative 0.0 0.0
Amortization of acquired intangible assets 0.0 0.0
Integration and acquisition costs 0.0 0.0
Reorganization costs 0.0 0.0
Gain/(loss) on sale of product rights   0.0
Total operating expenses 0.0 0.0
Operating income from continuing operations 0.0 0.0
Interest income/(expense), net (4.4) 5.4
Other income/(expense), net 0.0 0.0
Total other expense, net (4.4) 5.4
Income from continuing operations before income taxes and equity in earnings/(losses) of equity method investees (4.4) 5.4
Income taxes 1.1 (1.3)
Equity in income/(losses) of equity method investees, net of taxes 0.0 0.0
Income from continuing operations, net of taxes (3.3) 4.1
Gain from discontinued operations, net of taxes   0.0
Net income (3.3) 4.1
Comprehensive income/(loss) (3.3) 4.1
Baxalta Inc. (Baxalta Notes Subsidiary Issuer and SAIIDAC Notes Subsidiary Guarantor)    
Revenues:    
Product sales 0.0 0.0
Royalties and other revenues 0.0 0.0
Total revenues 0.0 0.0
Costs and expenses:    
Cost of sales 0.0 1.2
Research and development 0.0 0.0
Selling, general and administrative 2.9 5.7
Amortization of acquired intangible assets 0.0 0.0
Integration and acquisition costs 2.1 25.6
Reorganization costs 0.0 0.0
Gain/(loss) on sale of product rights   0.0
Total operating expenses 5.0 32.5
Operating income from continuing operations (5.0) (32.5)
Interest income/(expense), net (21.3) (21.4)
Other income/(expense), net 2.0 0.5
Total other expense, net (19.3) (20.9)
Income from continuing operations before income taxes and equity in earnings/(losses) of equity method investees (24.3) (53.4)
Income taxes 4.4 (19.9)
Equity in income/(losses) of equity method investees, net of taxes 92.6 (126.8)
Income from continuing operations, net of taxes 72.7 (200.1)
Gain from discontinued operations, net of taxes   0.0
Net income 72.7 (200.1)
Comprehensive income/(loss) 572.8 48.7
Non-Guarantor Non-Issuer Subsidiaries    
Revenues:    
Product sales 3,637.1 3,412.3
Royalties and other revenues 128.6 160.0
Total revenues 3,765.7 3,572.3
Costs and expenses:    
Cost of sales 1,132.4 1,325.8
Research and development 405.2 379.3
Selling, general and administrative 790.0 869.2
Amortization of acquired intangible assets 484.0 364.0
Integration and acquisition costs 233.2 90.4
Reorganization costs 5.3 5.5
Gain/(loss) on sale of product rights   (5.5)
Total operating expenses 3,050.1 3,028.7
Operating income from continuing operations 715.6 543.6
Interest income/(expense), net (66.4) (92.9)
Other income/(expense), net 21.8 4.0
Total other expense, net (44.6) (88.9)
Income from continuing operations before income taxes and equity in earnings/(losses) of equity method investees 671.0 454.7
Income taxes (49.7) 12.9
Equity in income/(losses) of equity method investees, net of taxes 0.8 (0.8)
Income from continuing operations, net of taxes 622.1 466.8
Gain from discontinued operations, net of taxes   20.2
Net income 622.1 487.0
Comprehensive income/(loss) 1,093.2 754.0
Non-Guarantor Subsidiaries of Baxalta Notes    
Revenues:    
Product sales 3,637.1 3,412.3
Royalties and other revenues 128.6 160.0
Total revenues 3,765.7 3,572.3
Costs and expenses:    
Cost of sales 1,132.4 1,325.8
Research and development 405.2 379.3
Selling, general and administrative 790.0 869.2
Amortization of acquired intangible assets 484.0 364.0
Integration and acquisition costs 233.2 90.4
Reorganization costs 5.3 5.5
Gain/(loss) on sale of product rights   (5.5)
Total operating expenses 3,050.1 3,028.7
Operating income from continuing operations 715.6 543.6
Interest income/(expense), net (70.8) (87.5)
Other income/(expense), net 21.8 4.0
Total other expense, net (49.0) (83.5)
Income from continuing operations before income taxes and equity in earnings/(losses) of equity method investees 666.6 460.1
Income taxes (48.6) 11.6
Equity in income/(losses) of equity method investees, net of taxes 0.8 (0.8)
Income from continuing operations, net of taxes 618.8 470.9
Gain from discontinued operations, net of taxes   20.2
Net income 618.8 491.1
Comprehensive income/(loss) $ 1,089.9 $ 758.1